i) With the aim of achieving uniformity of approach, to provide advice to the Racing Authorities of the member countries on policy, scientific and procedural matters concerning the Rules of Racing as they relate to prohibited substances.
ii) To recommend alterations to the Rules of Racing as they relate to prohibited substances.
iii) To recommend common policies and procedures where appropriate in the areas of sample collection, sample testing (including confirmatory analysis) and prohibited substances, and to monitor compliance by the member countries with these policies and procedures.
iv) To agree whether specified drugs fall within the List of Prohibited Substances.
v) To recommend the need, where appropriate, for new or varied threshold levels, for inclusion in the Rules of Racing.
vi) To promote liaison and discussion between the official racing laboratories and the official racing veterinary surgeons of the member countries.
vii) To promote inter – laboratory drug testing programmes, and to monitor the results vis-à-vis the official racing laboratories of the member countries.
viii) To agree research priorities and to promote joint approaches, where appropriate, for their achievement.
ix) To publish detection periods, agreed jointly between the official racing laboratories and other interested parties in the member countries, for therapeutic drugs commonly used in the horse.
x) To exchange drug intelligence and other relevant information between the member countries.
xi) To represent the Committee’s views, as appropriate, to other international forums in the field of doping control, to promote international agreement on policy issues and to promote research relevant to doping control internationally.
xii) To liaise as appropriate with external bodies.
xiii) To expand the number of member countries as appropriate.